A growing number of American parents are refusing standard newborn medical interventions that go well beyond childhood vaccines, including vitamin K injections and antibiotic eye ointment. A retrospective study published in the Journal of the American Medical Association, covering 5,096,633 births recorded between January 2017 and December 2024, found that nonreceipt of intramuscular vitamin K prophylaxis rose substantially over that period. The trend has accelerated alongside a federal policy shift that made the hepatitis B birth dose optional for some infants, raising concerns among pediatricians that parents now view all routine newborn care as negotiable.
Five Million Births Reveal a Sharp Climb in Refusals
The clearest evidence of this shift comes from a nationwide cohort study in JAMA that drew on electronic health records from Epic Systems’ Cosmos platform. Researchers examined more than five million births across the United States from January 2017 through December 2024 and measured how often newborns did not receive the standard intramuscular vitamin K shot. The study found that refusals or nonreceipt of the prophylaxis increased substantially over the study period, a finding that alarmed neonatal specialists because vitamin K prevents a rare but potentially fatal bleeding disorder in infants.
The same body of research attracted attention from major outlets. Reporting in the Washington Post noted that the JAMA analysis also documented parents refusing erythromycin eye ointment, a medication applied at birth to prevent bacterial eye infections that can cause blindness. What once seemed like an isolated pocket of vaccine hesitancy has broadened into a wider pattern of skepticism toward procedures that have been standard in delivery rooms for decades.
Why Parents Say No
The motivations behind these refusals are not monolithic, but they cluster around a few recurring themes. A peer-reviewed review in Hospital Pediatrics found that reported reasons for declining intramuscular vitamin K included fear of harm from the injection, a desire for a more “natural” birth experience, and a belief that oral vitamin K drops are an adequate substitute. That same review noted that parents who refused vitamin K were also more likely to refuse routine immunizations, suggesting the two decisions often stem from the same underlying distrust of medical protocols and institutions.
Social media has amplified these concerns. According to Reuters reporting, online platforms have fueled confusion and mistrust among parents, blurring the line between evidence-based medicine and personal wellness ideology. Viral posts casting routine newborn procedures as unnecessary or harmful reach expectant parents at a vulnerable decision-making moment, often without the context that these interventions were adopted precisely because the conditions they prevent, while uncommon, carry severe consequences.
Clinicians say that in many cases, parents arrive at the hospital with a preprinted “birth plan” downloaded from a parenting blog or social media group that already includes blanket refusals of vitamin K, hepatitis B, and eye ointment. By the time obstetric or pediatric teams meet these families, the conversation is no longer about weighing risks and benefits but about trying to unwind weeks or months of online messaging that framed standard care as optional or even dangerous.
A Federal Policy Shift That Widened the Door
The timing of this surge matters. In 2025, the Centers for Disease Control and Prevention adopted what it called individual-based decision-making for hepatitis B immunization for infants born to women who test negative for hepatitis B virus. That policy replaced the long-standing universal birth dose recommendation, which the Advisory Committee on Immunization Practices had maintained for medically stable infants weighing 2,000 grams or more.
The intent was to allow shared clinical decision-making for low-risk cases. But the practical effect, according to pediatricians quoted by Reuters, has been broader than expected. When a federal agency signals that one birth dose is now a matter of parental choice rather than standard protocol, some families extend that logic to every intervention offered in the delivery room. Vitamin K injections, erythromycin ointment, and even newborn screening tests get swept into the same conversation, not because the medical evidence changed for those procedures, but because the framing around parental authority did.
CDC clinical guidance still specifies that infants born to mothers with positive or unknown hepatitis B status should receive the vaccine within 12 hours of birth, along with hepatitis B immune globulin. For infants born to mothers who test negative for hepatitis B surface antigen, CDC guidance describes shared clinical decision-making on whether to give the birth dose, and if it is deferred, the first dose is typically given later as part of the routine childhood schedule rather than in the first day of life. But that distinction, clear on paper, often gets lost in a delivery room conversation where parents arrive with a blanket refusal plan shaped by online content rather than clinical nuance.
The broader federal health apparatus has tried to counter misinformation with more accessible communication. Agencies under the U.S. Department of Health and Human Services, accessible via the main HHS portal, host fact sheets, FAQ pages, and videos explaining why interventions like vitamin K and hepatitis B vaccination are recommended immediately after birth. Yet clinicians say these materials rarely have the same reach or emotional resonance as influencer posts that frame hospital protocols as an affront to parental autonomy.
What Doctors Are Up Against
Newborn care specialists emphasize that the biology is straightforward. As one physician explained in the Reuters coverage, babies are not born with sufficient vitamin K, which is crucial for normal blood clotting, and the vitamin does not cross the placenta in adequate amounts. Without supplementation, infants are at risk for vitamin K deficiency bleeding, which can cause spontaneous internal hemorrhage, including in the brain, sometimes with no warning signs before catastrophic collapse.
Unlike hepatitis B, where the risk is tied to maternal infection status, vitamin K deficiency bleeding can occur in otherwise healthy newborns with no known risk factors. That is why professional societies have endorsed a universal intramuscular dose shortly after birth rather than a selective or oral-only approach. Oral regimens used in some countries require multiple doses over weeks and may be less effective at preventing late-onset bleeding, especially if parents miss doses.
Doctors trying to convey these nuances often find themselves competing with online narratives that frame the vitamin K shot as an unnecessary pharmaceutical intrusion. Some parents cite outdated or discredited concerns about preservatives, while others invoke a generalized fear of “toxins” without specifying what they are worried about. Clinicians counter by pointing parents toward primary research databases such as the National Library of Medicine, where decades of safety and efficacy data on vitamin K prophylaxis and neonatal eye ointment are publicly available.
Yet evidence alone is rarely enough. Neonatologists and pediatric hospitalists describe spending precious minutes after delivery trying to secure consent for interventions that used to be routine, sometimes while a baby is already at risk for bleeding or infection. Hospitals have responded by revising consent forms, scripting conversations for nurses, and encouraging obstetric practices to raise these topics during prenatal visits, when parents may be more receptive and less overwhelmed.
Balancing Autonomy and Protection
The surge in refusals has reopened a difficult ethical debate: how far parental autonomy should extend when a newborn cannot speak for themselves. Some clinicians argue that declining proven, low-risk interventions that prevent severe harm edges toward medical neglect, especially when refusals are based on misinformation. Others emphasize that coercive approaches can backfire, driving families further from mainstream care and making it harder to ensure children receive vaccines and preventive services later in life.
For now, most hospitals are trying to thread the needle. They are training staff to listen carefully to parents’ fears, correct factual errors without condescension, and frame vitamin K, hepatitis B vaccination, and eye ointment as safeguards rather than mandates. Professional groups are urging colleagues to engage with pregnant patients earlier and more proactively, long before labor, so that delivery room conversations are confirmations of choices rather than last-minute debates.
Behind the policy shifts and online controversies is a simple reality: newborns are uniquely vulnerable, and the first hours of life offer a narrow window to prevent rare but devastating outcomes. Whether the current wave of skepticism can be reversed may depend less on new data than on rebuilding trust, between families and clinicians, and between the public and the institutions charged with protecting the smallest patients.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
